Results 91 to 100 of about 30,834 (256)
Clinical progress note: Rubella
Journal of Hospital Medicine, Volume 21, Issue 2, Page 179-182, February 2026.Visual Abstract Abstract Rates of rubella infection and congenital rubella syndrome decreased significantly since the introduction of the rubella vaccine in 1969. Endemic rubella was declared eliminated in the United States in 2004, and since 2012, all rubella cases in the United States have been associated with infections acquired abroad. With vaccine
Adam E. Gailani +2 more
wiley +1 more source
The Turkish Journal of Pediatrics, 2000 A total of 44 children aged between 15-18 months were randomly vaccinated either with a new measles-mumps-rubella (MMR) vaccine (Priorix, SmithKline Beecham) or a commercially available MMR vaccine (MMR-II, Merck) to compare the reactogenicity and
G Kanra, M Ceyhan, E Ozmert
doaj
MedComm, Volume 7, Issue 2, February 2026.Tumor‐associated macrophages are the most abundant immune cells in the tumor microenvironment, driving malignant progression and treatment resistance. This review summarizes the protumor mechanisms of TAMs (including phagocytosis modulation, metabolic reprogramming, exosomal communication, and immune interactions), evaluates three major strategies ...
Wurihan Bao +8 more
wiley +1 more source
Anatomy of a Health Scare: Education, Income and the MMR Controversy in the UK [PDF]
One theory for why there is a strong education gradient in health outcomes is that more educated individuals more quickly absorb new information about health technology.
Anderberg, Dan +2 more
core +3 more sources
EurosurveillanceIntroduction Since the late 2000s, several major measles epidemics have occurred in Europe, including France. In 2017, the French Health Ministry extended from three to 11 the number of mandatory childhood vaccines required for preschool and primary ...
Pierre Verger
doaj +1 more source
Vaccine Epidemiology and Decision-Making: A Bryant Student Focus [PDF]
, 2018 The Centers for Disease Control and Prevention estimate that influenza has resulted in between 9.2 and 35.6 million illnesses and between 12,000 and 56,000 deaths annually since 2010 (1).
Coburn, Hannah
core +1 more source
IKAROS Associated Immunodeficiency and Thrombotic Thrombocytopenic Purpura
Pediatric Blood &Cancer, Volume 73, Issue 2, February 2026.ABSTRACT Pathogenic variants in IKZF1 (IKAROS) are linked to immunodeficiency, malignancy, and immune dysregulation. We describe a family with a rare IKZF1 variant presenting with humoral immunodeficiency and thrombotic thrombocytopenic purpura (TTP). A non‐consanguineous family was clinically monitored; clinical, immunological, and genetic data (exome
Ilia Spivak +7 more
wiley +1 more source
Response to third rubella vaccine dose
Human Vaccines & Immunotherapeutics, 2018 Limited data exist on the immunogenicity of a third dose of the measles, mumps, and rubella vaccine (MMR). In this study, our aim was to evaluate the long-term rubella immunogenicity afforded by two childhood MMR doses of the Norwegian vaccination ...
Lotta Siira +5 more
doaj +1 more source
A Bayesian space–time model for clustering areal units based on their disease trends [PDF]
, 2018 Population-level disease risk across a set of non-overlapping areal units varies in space and time, and a large research literature has developed methodology for identifying clusters of areal units exhibiting elevated risks.
Lawson, Andrew +3 more
core +2 more sources
Vaccination Recommendations in Patients With Atopic Dermatitis Treated With JAK Inhibitors
International Journal of Dermatology, Volume 65, Issue 2, Page 230-237, February 2026.Inmunization and Screening Protocol for the Safe Initiation of JAK Inhibitors. ABSTRACT Atopic dermatitis therapy has undergone a revolutionary change with the introduction of Janus kinase (JAK) inhibitors. Despite their general safety profile, these immunomodulatory drugs require special precautions with respect to infection risk and vaccine ...
Mariano Ara‐Martín +5 more
wiley +1 more source